4 - SBC Medical Group Holdings Inc (0001930313) (Issuer)

4 - SBC Medical Group Holdings Inc (0001930313) (Issuer)

4 - SBC Medical Group Holdings Inc (0001930313) (Issuer)

3 - SBC Medical Group Holdings Inc (0001930313) (Issuer)

3/A - SBC Medical Group Holdings Inc (0001930313) (Issuer)

4 - SBC Medical Group Holdings Inc (0001930313) (Issuer)

DEFA14A - SBC Medical Group Holdings Inc (0001930313) (Filer)

DEF 14A - SBC Medical Group Holdings Inc (0001930313) (Filer)

8-K - SBC Medical Group Holdings Inc (0001930313) (Filer)

PRE 14A - SBC Medical Group Holdings Inc (0001930313) (Filer)

10-Q - SBC Medical Group Holdings Inc (0001930313) (Filer)

8-K - SBC Medical Group Holdings Inc (0001930313) (Filer)

10-K/A - SBC Medical Group Holdings Inc (0001930313) (Filer)

8-K - SBC Medical Group Holdings Inc (0001930313) (Filer)

424B7 - SBC Medical Group Holdings Inc (0001930313) (Filer)

424B7 - SBC Medical Group Holdings Inc (0001930313) (Filer)

BTIG Research initiated coverage of SBC Medical Group with a rating of Buy and set a new price target of $8.00

IRVINE, Calif., May 26, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a Medical Services Organization providing management support across a wide range of healthcare fields, today announced its participation in several upcoming investor conferences in May and June 2026. SBC Medical will deliver webcast presentations and conduct one-on-one meetings with institutional investors. Below is a summary of the Company's scheduled participation in upcoming investor conferences: ConferenceDateTime (ET)FormatLinkLytham Partners– Spring 2026 Investor ConferenceMay 28—1-on-1 MeetingsRegistrationNoble Capital Markets– June 2026 Emerging G

IRVINE, Calif., May 22, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a Medical Services Organization providing management support across a wide range of healthcare fields, today announced that its consulting partner in Thailand, BLEZ ASIA Co., Ltd. ("BLEZ ASIA") held an inauguration reception on May 21, 2026, to celebrate the opening of a new aesthetic dermatology section at BLEZ CLINIC in the Asok district of Bangkok. The event marks a significant milestone in SBC Medical's efforts to bring high-quality aesthetic healthcare services to the Thai market, with the section's service launch scheduled for June 2026. Thailand'

SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a Medical Services Organization providing management support across a wide range of healthcare fields, today announced its financial results for the three months ended March 31, 2026. First Quarter 2026 Highlights Total revenues were $43 million, representing a 9% year-over-year decrease. Net income attributable to SBC Medical Group Holdings Incorporated was $11 million, representing a 47% year-over-year decrease. Net income margin was 26% for the first quarter of 2026, representing a year-over-year decrease of 19 percentage points. Earnings per share, which is defined as net income attributabl

IRVINE, Calif., May 01, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a Medical Services Organization providing management support across a wide range of healthcare fields, today announced it will release its financial results for the first quarter ended March 31, 2026, before U.S. market open on May 14, 2026. Management will host an earnings conference call on May 14, 2026, at 8:30 a.m. Eastern Time. A question‑and‑answer session with analysts and investors will follow the prepared remarks. Please register in advance for the conference using the link provided below.https://zoom.us/webinar/register/WN_6RZgrwsUREiRpAmBBGTik

SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("the Company"), a Management Service Organization operating a wide range of franchise businesses across diverse medical fields, today announced the closing of its previously announced underwritten secondary public offering of 3,100,000 shares of the Company's common stock by Dr. Yoshiyuki Aikawa (the "Selling Stockholder") at the public offering price of $3.25 per share. The proceeds from the offering to the Selling Stockholder were approximately $10.1 million, before deducting underwriting discounts and commissions. The Company did not sell any shares of its common stock in the offering. The Selling Stockholder received all of the pro

SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("the Company"), a Management Service Organization operating a wide range of franchise businesses across diverse medical fields, today announced the pricing of the underwritten secondary public offering of 3,100,000 shares of the Company's common stock by Dr. Yoshiyuki Aikawa (the "Selling Stockholder") at the public offering price of $3.25 per share. Additionally, the Selling Stockholder has granted the underwriters a 45-day option to purchase up to an additional 465,000 shares of the Company's common stock. The offering is expected to close on or about April 21, 2026, subject to customary closing conditions. The Company is not selling

NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- PRISM MarketView today published an exclusive Q&A feature with Yoshiyuki Aikawa, Chairman and Chief Executive Officer of SBC Medical Group Holdings (NASDAQ:SBC), a Japan-based management services organization building a large and growing global aesthetic medical network. In the interview, Aikawa discusses SBC Medical's evolution from a domestic platform into a globally scalable model, as well as the company's recent operational inflection, U.S. market entry, and long-term growth strategy. The Q&A highlights several key themes, including: Improving unit economics, with Q4 average revenue per visit increasing 11% year over year to $316, signa

Q4 EPS more than doubles to $0.14 as profitability improves significantly year over year SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced its financial results for the fourth quarter of fiscal year 2025 (three months ended December 31, 2025) and for the full fiscal year 2025 (twelve months ended December 31, 2025). Fourth Quarter 2025 Highlights Total revenues were $40 million, representing an 11% year-over-year decrease. Net Income attributable to SBC Medical Group was $14 million, representing a 117% year-over-year

Pioneering the "Performance Medicine" category for full-scale entry into the longevity market — targeting a global market projected to reach $2 trillion by 2035 SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced "SBC Wellness 2.0," a new wellness and longevity platform that combines aesthetic healthcare, preventative care, and data-driven health management. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260323000188/en/SBC Medical Announces Next-Generation Wellness

 Accelerating multi-branding strategy in aesthetic healthcare with global presence in Tokyo's premier district SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced that its specialized aesthetic brand, "NEO Skin Clinic," will open its flagship location in Tokyo's Ginza district, a globally recognized medical tourism hub and highly competitive district, on Saturday, March 28, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260312457783/en/SBC Medical Announces Op

SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a global provider of comprehensive consulting and management services to medical corporations and their clinics, today announced the appointment of Sheng-FU Hsiao as Chief Technology Officer (CTO), effective March 1, 2026. This appointment aligns with the Company's 2026 management strategy, "Sophistication of Management Structure through AI and DX," and strengthens its leadership team to accelerate technological transformation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260302064873/en/SBC Medical Appoints Sheng-FU Hsiao as CTO Leveraging

SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical"), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced the appointment of Dr. Steven R. Cohen, a globally recognized leader in plastic and craniofacial surgery, as Medical Strategy Advisor. His appointment marks a significant step in the company's strategy to expand its global footprint and enhance its medical excellence. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250714547888/en/Dr. Cohen Dr. Cohen is the Founder of Faces+, an advanced aesthetic and reconstructive surgery center

IRVINE, Calif., July 01, 2025 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical"), a global franchise and provider of services for aesthetic clinics, is pleased to announce the appointment of Shinya Inoue as Chief Marketing Officer (CMO), effective July 1, 2025. As CMO of SBC Medical, Mr. Inoue will lead efforts to enhance the brand value of the group's portfolio, including Shonan Beauty Clinic, one of Japan's largest aesthetic medical brands. He will also spearhead the evolution and optimization of the company's marketing infrastructure with a strong focus on digital innovation. Through strategic initiatives that address the increasing diversity of

SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a Medical Services Organization providing management support across a wide range of healthcare fields, today announced its financial results for the three months ended March 31, 2026. First Quarter 2026 Highlights Total revenues were $43 million, representing a 9% year-over-year decrease. Net income attributable to SBC Medical Group Holdings Incorporated was $11 million, representing a 47% year-over-year decrease. Net income margin was 26% for the first quarter of 2026, representing a year-over-year decrease of 19 percentage points. Earnings per share, which is defined as net income attributabl

IRVINE, Calif., May 01, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a Medical Services Organization providing management support across a wide range of healthcare fields, today announced it will release its financial results for the first quarter ended March 31, 2026, before U.S. market open on May 14, 2026. Management will host an earnings conference call on May 14, 2026, at 8:30 a.m. Eastern Time. A question‑and‑answer session with analysts and investors will follow the prepared remarks. Please register in advance for the conference using the link provided below.https://zoom.us/webinar/register/WN_6RZgrwsUREiRpAmBBGTik

Q4 EPS more than doubles to $0.14 as profitability improves significantly year over year SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced its financial results for the fourth quarter of fiscal year 2025 (three months ended December 31, 2025) and for the full fiscal year 2025 (twelve months ended December 31, 2025). Fourth Quarter 2025 Highlights Total revenues were $40 million, representing an 11% year-over-year decrease. Net Income attributable to SBC Medical Group was $14 million, representing a 117% year-over-year

IRVINE, Calif., March 13, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced it will release its financial results for the fourth quarter and fiscal year ended December 31, 2025, before U.S. market open on March 27, 2026.  Management will host an earnings conference call on March 27, 2026, at 8:30 a.m. Eastern Time to discuss the Company's financial performance, operational highlights, and key priorities for 2026. A question‑and‑answer session with analysts and investors will follow the prepared remark

SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced its financial results for the third quarter of fiscal year 2025 (three months ended September 30, 2025) and for the third quarter cumulative of fiscal year 2025 (Year-to-Date 2025, nine months ended September 30, 2025) Third Quarter 2025 Highlights Total revenues were $43 million, representing an 18% year-over-year decrease. Income from operations was $16 million, representing a 15% year-over-year increase. Net Income attributable to SBC Medical Group was $13 mill

SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced that it will release its Q3 2025 financial results on Friday, November 14, 2025, before the U.S. market opens. The Company will hold a Earnings Call on Monday, November 17, 2025 at 5:00 p.m. Eastern Time to discuss the financial results and take questions live. Please register in advance for the conference using the link provided below. https://edge.media-server.com/mmc/p/e2znwqtx It will automatically direct you to the registration page for "SBC Q3 2025 Financial Resu

SBC Medical Group Holdings Incorporated (NASDAQ:SBC, "SBC Medical" or the "Company")), a global owner, operator and provider of management services and products to cosmetic treatment centers, today announced its financial results for the second quarter of fiscal year 2025 (three months ended June 30, 2025) and for the first half of fiscal year 2025 (six months ended June 30, 2025). Second Quarter 2025 Highlights Total revenues were $43 million, representing an 18% year-over-year decrease. Income from operations was $15 million, representing a 47% year-over-year decrease. Net Income attributable to SBC Medical Group was $2.5 million, representing an 87% year-over-year decrease.

SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a global franchise and provider of services for aesthetic clinics, today announced that it will report its Q2 2025 financial results on Wednesday, August 13, 2025, before the U.S. market opens. The Company will hold a conference call on Wednesday, August 13, 2025 at 8:30 am Eastern Time (or Wednesday, August 13, 2025 at 9:30 pm Japan Time) to discuss the financial results and take questions live. Please register in advance of the conference using the link provided below. https://edge.media-server.com/mmc/p/ukc9sp9j It will automatically direct you to the registration page of "SBC Q2 2025 Financial R

SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a global franchise and provider of services for aesthetic clinics, announced that, on July 17, 2025, it acquired MB career lounge, Co., Ltd. ("MB career lounge"), a privately-held provider of management support services for medical institutions, specializing in consulting, training, and human resources solutions in Japan, through a share purchase transaction for cash consideration. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250717637525/en/JUN CLINIC Through this transaction, JUN CLINIC, operated by Medical Corporation Misakikai and suppor

SBC Medical Group Holdings Incorporated (NASDAQ:SBC, "SBC Medical" or the "Company")), a global owner, operator and provider of management services and products to cosmetic treatment centers, today announced its financial results for the three months ended March 31, 2025. First Quarter 2025 Highlights Total revenues were $47 million, representing a 14% year-over-year decrease. Income from operations was $24 million, representing a 1% year-over-year decrease. Net Income attributable to SBC Medical Group was $22 million, representing a 15% year-over-year increase. Earnings per share, which is defined as net income attributable to the Company divided by the weighted average number of

SC 13D/A - SBC Medical Group Holdings Inc (0001930313) (Subject)

SC 13D/A - SBC Medical Group Holdings Inc (0001930313) (Subject)

SC 13D/A - SBC Medical Group Holdings Inc (0001930313) (Subject)

SC 13D - SBC Medical Group Holdings Inc (0001930313) (Subject)